SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-058479
Filing Date
2023-03-03
Accepted
2023-03-02 18:29:06
Documents
18
Period of Report
2023-03-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d408746d8k.htm   iXBRL 8-K 30186
2 EX-99.1 d408746dex991.htm EX-99.1 118390
3 EX-99.2 d408746dex992.htm EX-99.2 6528
8 GRAPHIC g408746page01aa.jpg GRAPHIC 10559
9 GRAPHIC g408746page01b.jpg GRAPHIC 9295
10 GRAPHIC g408746page01c.jpg GRAPHIC 5919
  Complete submission text file 0001193125-23-058479.txt   367131

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20230302.xsd EX-101.SCH 3143
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20230302_def.xml EX-101.DEF 13952
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20230302_lab.xml EX-101.LAB 23051
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20230302_pre.xml EX-101.PRE 14830
12 EXTRACTED XBRL INSTANCE DOCUMENT d408746d8k_htm.xml XML 5562
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36697 | Film No.: 23700849
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences